Follow Dr. Webster on Substack

Going forward, all my new articles will appear on Substack. This will give us a cleaner, more reliable way to stay connected with thoughtful, evidence-based commentary on pain, addiction, health policy, and the science that matters most to patients, and people interested in the health-related topics I write about.

Who Is to Blame for Skyrocketing Drug Prices?

By Lynn Webster, M.D. / June 29, 2019 /

This article, in a slightly edited form, first appeared in The Hill on July 27, 2017. Drug Prices Are Soaring Across the board, drug prices are soaring. Even the cost of cancer medications are so high that some patients are delaying cancer treatments or skipping them altogether. But who is most responsible for higher drug prices: pharmaceutical…

Processed Foods

By Lynn Webster, M.D. / June 22, 2019 /

Some research suggests that the products’ packaging can leach such chemicals as bisphenol A (BPA) and perfluoroalky and polyfluoroalkyl substances (PFAS), or that these toxins may act as endocrine interrupters and cause cancers, infertility, and other health problems.

What “Rocketman” Tells Us About Pain and Addiction

By Lynn Webster, M.D. / June 15, 2019 /

Adverse childhood experiences rewire the brain. The heightened response to stress that some children develop can affect the reward center of the brain and the executive functioning of the prefrontal cortex. It can also result in maladaptive behaviors associated with pain and addiction.

Is Postpartum Pain Control a Crap Shoot?

By Lynn Webster, M.D. / June 8, 2019 /

I worried that the hospital’s choice to lessen the amount of drugs prescribed, rather than focusing on patients’ clinical needs, might mean my daughter’s need for pain control would be unmet. The idea of my daughter enduring inadequately treated pain haunted me, as it would any father, but as a pain specialist, it may have troubled me even more.

Detoxification as Performance Art

By Lynn Webster, M.D. / June 1, 2019 /

This article, in a slightly edited form, first appeared on Pain News Network on May 31, 2019.   “Treatment Box: Rebekkah’s Story” won an Emmy for Outstanding Special Class – Short Format Daytime Program at the 46th Annual Daytime Creative Arts Emmy Awards. The 6-minute video was produced by The Truth About Opioids, which is an opioid…

Honoring Our Veterans on Memorial Day

By Lynn Webster, M.D. / May 25, 2019 /

Those statistics are difficult to read anytime, but they seem especially troubling as the United States commemorates Memorial Day. This is the time for us to acknowledge that those who have served our country deserve the best medical care available.

How to Know If You Are Addicted

By Lynn Webster, M.D. / May 18, 2019 /

This article, in a slightly edited form, first appeared in Consumer Health Digest on May 15, 2019.   Everyone has heard the phrase “opioid addiction,” but few understand what that really means. Journalists, patients, and even many doctors believe they know what addiction is, but they are often wrong. This leads many people to be diagnosed…

Don’t Lose Sleep Over It

By Lynn Webster, M.D. / May 11, 2019 /

Black box warnings may be alarming. However, they are not meant to scare you into panicking and discontinuing medication that you need. Their primary purpose is to inform prescribers and patients about dangers they may pose.

Is the Drug Enforcement Administration (DEA) Overreaching Its Authority?

By Lynn Webster, M.D. / May 4, 2019 /

Unquestionably, prescribers should be held to a high standard of care at all times. However, it is the responsibility of state medical boards to hold them to that standard. It is not the DOJ’s role to determine the quality or boundaries of the practice of medicine.

Is Fentanyl a Weapon of Mass Destruction?

By Lynn Webster, M.D. / April 27, 2019 /

However, before we classify the chemical fentanyl as a WMD, we need to know what that would mean for its legitimate use during surgery, or for cancer and chronic pain patients. Access to the medication for the treatment of pain must be part of the calculus in assessing if a relatively safe and effective drug should be classified as a WMD.

Archives

Categories